These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3319645)

  • 1. Effect of the calcium antagonist nilvadipine on haemodynamics at rest and during cold stimulation in essential hypertension.
    Takabatake T; Yamamoto Y; Nakamura S; Hashimoto N; Satoh S; Yamada Y; Ohta H; Hattori N
    Eur J Clin Pharmacol; 1987; 33(3):215-9. PubMed ID: 3319645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of regression of vascular structural changes and its relation to cytosolic free calcium in hypertensives after nilvadipine treatment.
    Ueno H; Takata M; Oh-hashi S; Tomoda F; Yasumoto K; Inoue H
    J Hum Hypertens; 1995 Sep; 9(9):735-9. PubMed ID: 8551487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte sodium cannot predict hypotensive effects of calcium channel blockers.
    Oshima T; Matsuura H; Ozono R; Ishida-Kainouchi M; Ishida T; Ishibashi K; Watanabe M; Okura Y; Kanbe M; Kajiyama G
    Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1227-31. PubMed ID: 8139134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nicardipine on haemodynamic response to stress in hypertension.
    Takabatake T; Yamamoto Y; Nakamura S; Hashimoto N; Satoh S; Yamada Y; Kobayashi K
    Eur J Clin Pharmacol; 1992; 42(3):265-9. PubMed ID: 1577044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P; White W; Digranes O; Helland B; Jordal O; Stray T
    Postgrad Med J; 1991; 67 Suppl 5():S20-3. PubMed ID: 1839433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of calcium antagonists in the treatment of essential hypertension.
    Klein W; Brandt D; Vrecko K; Härringer M
    Circ Res; 1983 Feb; 52(2 Pt 2):I174-81. PubMed ID: 6831651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hemodynamic effects of nilvadipine, a new calcium channel blocker, in patients with congestive heart failure.
    Sato H; Ikenouchi H; Aoyagi T; Matsui H; Mochizuki T; Momomura S; Serizawa T; Iizuka M; Sugimoto T
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):317-22. PubMed ID: 1689429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central hemodynamic changes of calcium antagonists at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S139-48. PubMed ID: 2442506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses.
    Koch G; Fransson L
    Am J Hypertens; 1991 Aug; 4(8):709-13. PubMed ID: 1681821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina.
    Brogden RN; McTavish D
    Drugs Aging; 1995 Feb; 6(2):150-71. PubMed ID: 7711361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.
    Leonetti G; Cuspidi C; Sampieri L; Terzoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S319-24. PubMed ID: 6184561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris.
    Jackson NC; Silke B; Verma SP; Reynolds G; Hafizullah M; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():11-6. PubMed ID: 6527973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist.
    Honerjäger P; Seibel K
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S15-21. PubMed ID: 1283184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
    Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T
    Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension.
    Levenson J; Simon AC; Bouthier J; Maarek BC; Safar ME
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):107S-113S. PubMed ID: 4027144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of KRN4884, a novel K channel opener, on the cardiovascular system in anesthetized dogs: a comparison with levcromakalim, nilvadipine, and nifedipine.
    Izumi H; Jinno Y; Kaneta S; Tanaka Y; Okada Y; Izawa T; Ogawa N
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):189-97. PubMed ID: 7475042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic effects of nifedipine in essential hypertension at rest and during exercise.
    Lund-Johansen P; Omvik P
    J Hypertens; 1983 Aug; 1(2):159-63. PubMed ID: 6681035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.